International Clinical Trial: Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315828) titled 'Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery' on Dec. 20, 2025.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Condition: Giant Cell Tumor of Bone

Intervention: Drug: Indocyanine Green

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: January 2026

Target Sample Size: 40

To know more, visit https://clinicaltrials.gov/study/NCT07315828

Pub...